NGeneBio Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	8,996	4,430	19,275	24,897	16,296
Short-Term Investments	75.2	58.42	129.05	10,021	8,011
Trading Asset Securities	3,047	3,008	3,023	-	-
Cash & Short-Term Investments	12,118	7,496	22,427	34,918	24,307
Cash Growth	121.34%	-66.57%	-35.77%	43.66%	-
Accounts Receivable	732.96	699.76	788.95	1,125	1,574
Other Receivables	45.98	62.06	210.77	51.09	58.06
Receivables	778.94	761.82	999.72	1,176	1,632
Inventory	1,105	2,074	1,695	2,968	1,219
Prepaid Expenses	51.61	120.57	121.5	141.72	79.67
Other Current Assets	1,069	1,220	1,779	3,868	136.73
Total Current Assets	15,123	11,672	27,021	43,072	27,374
Property, Plant & Equipment	8,740	12,172	9,343	8,684	8,092
Long-Term Investments	2,973	1,057	2,837	1,378	5,451
Goodwill	2,841	5,388	416.32	416.32	416.32
Other Intangible Assets	1,556	2,427	1,456	1,224	1,247
Other Long-Term Assets	109.98	233.05	1,208	1,389	1,287
Total Assets	31,343	32,950	42,282	56,164	43,867
Accounts Payable	128.41	376.67	162.75	69.18	172.85
Accrued Expenses	503.66	476.88	253.59	235.99	188.37
Short-Term Debt	6,757	6,750	11,056	10,786	6,100
Current Portion of Long-Term Debt	-	-	-	-	362
Current Portion of Leases	325.54	1,028	241.11	295.95	161.89
Current Unearned Revenue	-	-	0	20.17	18.33
Other Current Liabilities	4,183	3,893	12,103	17,594	1,051
Total Current Liabilities	11,897	12,525	23,816	29,001	8,055
Long-Term Debt	-	-	-	-	500
Long-Term Leases	239.15	1,242	146.88	374.62	82.69
Other Long-Term Liabilities	9.4	10.19	150.52	165.38	43.69
Total Liabilities	13,681	15,241	26,048	30,837	9,869
Common Stock	25,038	19,819	12,889	12,526	12,431
Additional Paid-In Capital	65,394	60,909	55,102	52,570	51,982
Retained Earnings	-74,474	-66,297	-53,941	-40,886	-31,381
Comprehensive Income & Other	2,005	2,547	2,244	1,086	965.73
Total Common Equity	17,963	16,977	16,295	25,297	33,998
Minority Interest	-300.7	731.71	-60.68	30.24	-
Shareholders' Equity	17,662	17,709	16,234	25,327	33,998
Total Liabilities & Equity	31,343	32,950	42,282	56,164	43,867
Total Debt	7,322	9,019	11,444	11,456	7,207
Net Cash (Debt)	4,796	-1,523	10,983	23,462	17,100
Net Cash Growth	-	-	-53.19%	37.20%	-
Net Cash Per Share	271.16	-91.44	865.85	1880.24	1382.64
Filing Date Shares Outstanding	25.04	19.82	12.89	12.53	12.43
Total Common Shares Outstanding	25.04	19.82	12.89	12.53	12.43
Working Capital	3,225	-852.15	3,205	14,072	19,319
Book Value Per Share	717.43	856.62	1264.22	2019.58	2734.94
Tangible Book Value	13,566	9,162	14,422	23,656	32,334
Tangible Book Value Per Share	541.81	462.28	1118.95	1888.61	2601.11
Land	2,696	2,696	2,696	2,584	2,584
Buildings	4,044	4,044	4,044	3,040	3,040
Machinery	7,134	8,422	4,962	4,569	3,699
Construction In Progress	-	-	-	9.23	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.